Cardiac medications escoliosis consecuencias

The following chart gives you a quick "at-a-glance" look at many typical cardiac medications. Your prescription may have a different name from the ones listed on this chart. Brand names commonly available in the U.S. are shown in parentheses after the generic name for each drug.

*Some of the major types of commonly prescribed cardiovascular medications are summarized in this section. For your information and reference, we have included generic names as well as major trade names to help you identify what you may be taking; however, the AHA is not recommending or endorsing any specific products. If your prescription medication isn’t on this list, remember that your healthcare provider and pharmacist are your best sources of information.


It’s important to discuss all of the drugs you take with your doctor and understand their desired effects and possible side effects. Never stop taking a medication and never change your dose or frequency without first consulting your doctor.

Use these handy "At-A-Glance" charts to gain a quick understanding of these common cardiac medications you may be prescribed. If you need more help understanding what medication you’re taking and why you’re taking it, print this chart out and take it to your doctor.

Patients who have had heart attacks, patients who are treated with stents in their coronary arteries, and some patients who undergo coronary artery bypass graft surgery (CABG) are treated at the same time with two types of antiplatelet agents to prevent blood clotting. This is called dual antiplatelet therapy (DAPT).

One antiplatelet agent is aspirin. Almost everyone with coronary artery disease, including those who have had a heart attack, stent, or CABG are treated with aspirin for the rest of their lives. A second type of antiplatelet agent, called a P2Y 12 inhibitor, is usually prescribed for months or years in addition to the aspirin therapy.

• If you did not have a heart attack, but have atherosclerosis in your coronary arteries and had a stent placed, you should be on clopidogrel for at least 1-6 months, depending on the type of stent which was placed, risk of clotting the stent, and bleeding risk.

• If you had a heart attack and a coronary artery stent placed, or you are being medically managed for your heart attack (specifically non-ST elevation myocardial infarction ( NSTEMI), you should also be on a P2Y 12 inhibitor for approximately 6-12 months. In some cases, it may be advisable to be on DAPT for a longer duration. This will need to be discussed with your healthcare provider. There are three P2Y 12 inhibitors that doctors prescribe, which are clopidogrel, prasugrel, and ticagrelor. Studies have shown that two of these drugs (ticagrelor, prasugrel) are “stronger” than clopidogrel, and are a little better at decreasing the complications of blood clots. These two stronger agents, however, slightly increase bleeding. One of these drugs (prasugrel) should not be used by patients who have had a stroke or a transient ischemic attack (TIA). Which one these medications your doctor prescribes will be based on what he or she feels is best for you, based on your risk of blood clots and bleeding. For example, according to the FDA, clopidogrel does decrease the risk of stroke and MI, but does not change the risk of death for specific patients. So, the choice of what type of medication, cost of the medication and duration of treatment will be determined in conjunction with your healthcare provider.

• Some patients who undergo coronary artery bypass surgery may be treated with a P2Y 12 inhibitor for a year after the bypass operation. After this, the P2Y 12 inhibitor may be stopped, but the patient continues on aspirin. Your surgeon will discuss if this treatment will be needed.

These are general recommendations for the duration and type of dual anti-platelet therapy which should be used after coronary artery stenting, heart attack and CABG. Again, it is important to talk to your doctor about your specific treatment plan.